Enhanced CD36 expression changes the role of Nrf2 activation from anti-atherogenic to pro-atherogenic in apoE-deficient mice

Atherosclerosis

Volumn 225, Issue 1, 2012, Pages 83-90

  Sawada, Hirotaka ^a   Saito, Yoshiro ^a   Noguchi, Noriko ^a  

^a DOSHISHA UNIVERSITY   (Japan)

Author keywords

ApoE deficient; Atherosclerosis; CD36; Nrf2; Oxidative stress; Radical scavenging antioxidant

Indexed keywords

12 (4 HYDROXY 3 METHOXYPHENYL) 10 OXODODEC 8 ENOIC ACID ETHYLESTER; 12 [3 METHOXY 4 (METHOXYMETHOXY)PHENYL] 10 OXODODEC 8 ENOIC ACID ETHYL ESTER; 8 [3 (4 HYDROXY 3 METHOXYPHENYL)PROPANAMIDO]OCTANOIC ACID ETHYLESTER; APOLIPOPROTEIN E; CD36 ANTIGEN; CURCUMIN; SHOGAOL; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG STABILITY; DRUG STRUCTURE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD36; ANTIOXIDANTS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CAPRYLATES; CATECHOLS; CURCUMIN; FREE RADICAL SCAVENGERS; LAURIC ACIDS; MACROPHAGES; MALE; MICE; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; UP-REGULATION;

EID: 84867874555     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.08.023     Document Type: Article

References (29)

1. Steinberg D., Witztum J.L. Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol 2010 Dec, 30(12):2311-2316.
2. Dinkova-Kostova A.T., Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 2008 Jun, 52(Suppl. 1):S128-S138.
3. Ishii T., Itoh K., Takahashi S., et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000 May 26, 275(21):16023-16029.
4. Kaliora A.C., Dedoussis G.V., Schmidt H. Dietary antioxidants in preventing atherogenesis. Atherosclerosis 2006 Jul, 187(1):1-17.
5. Noguchi N., Niki E. Phenolic antioxidants: a rationale for design and evaluation of novel antioxidant drug for atherosclerosis. Free Radic Biol Med 2000 May 15, 28(10):1538-1546.
6. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003 Jun 14, 361(9374):2017-2023.
7. Sesso H.D., Buring J.E., Christen W.G., et al. Vitamins E and C in the prevention of cardiovascular disease in men: the physicians' health study II randomized controlled trial. J Am Med Assoc 2008 Nov 12, 300(18):2123-2133.
8. Gotoh N., Shimizu K., Komuro E., Tsuchiya J., Noguchi N., Niki E. Antioxidant activities of probucol against lipid peroxidations. Biochim Biophys Acta 1992 Oct 30, 1128(2-3):147-154.
9. Itoh K., Wakabayashi N., Katoh Y., et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999 Jan 1, 13(1):76-86.
10. Kobayashi A., Kang M.I., Watai Y., et al. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 2006 Jan, 26(1):221-229.
11. Nakamura Y., Miyoshi N. Electrophiles in foods: the current status of isothiocyanates and their chemical biology. Biosci Biotechnol Biochem 2010, 74(2):242-255.
12. Asakura T., Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Res 1990 Apr, 66(4):1045-1066.
13. Gibson C.M., Diaz L., Kandarpa K., et al. Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arterioscler Thromb 1993 Feb, 13(2):310-315.
14. Chen X.L., Varner S.E., Rao A.S., et al. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 2003 Jan 10, 278(2):703-711.
15. Dai G., Vaughn S., Zhang Y., Wang E.T., Garcia-Cardena G., Gimbrone M.A. Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ Res 2007 Sep 28, 101(7):723-733.
16. Takabe W., Warabi E., Noguchi N. Anti-atherogenic effect of laminar shear stress via Nrf2 activation. Antioxid Redox Signal 2011 Sep 1, 15(5):1415-1426.
17. Barajas B., Che N., Yin F., et al. NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection. Arterioscler Thromb Vasc Biol 2011 Jan, 31(1):58-66.
18. Sussan T.E., Jun J., Thimmulappa R., et al. Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PLoS One 2008, 3(11):e3791.
19. Niki E., Omata Y., Fukuhara A., Saito Y., Yoshida Y. Assessment of radical scavenging capacity and lipid peroxidation inhibiting capacity of antioxidant. J Agric Food Chem 2008 Sep 24, 56(18):8255-8260.
20. Fujiwara Y., Kiyota N., Hori M., et al. Esculeogenin A, a new tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in ApoE-deficient mice by inhibiting ACAT. Arterioscler Thromb Vasc Biol 2007 Nov, 27(11):2400-2406.
21. Noguchi N. Action of curcumin as an antioxidant against lipid peroxidation. J Jpn Oil Chem Soc 1994, 43(12):1045-1051.
22. Zingg J.M., Hasan S.T., Cowan D., Ricciarelli R., Azzi A., Meydani M. Regulatory effects of curcumin on lipid accumulation in monocytes/macrophages. J Cell Biochem 2012 Mar, 113(3):833-840.
23. Yuan H.Y., Kuang S.Y., Zheng X., et al. Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/caveolin-1 signaling pathway in vascular smooth muscle cells. Acta Pharmacol Sin 2008 May, 29(5):555-563.
24. Olszanecki R., Jawien J., Gajda M., et al. Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J Physiol Pharmacol 2005 Dec, 56(4):627-635.
25. Ejaz A., Wu D., Kwan P., Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 2009 May, 139(5):919-925.
26. Maruyama A., Tsukamoto S., Nishikawa K., et al. Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements. Arch Biochem Biophys 2008 Sep 1, 477(1):139-145.
27. Nagy L., Tontonoz P., Alvarez J.G., Chen H., Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998 Apr 17, 93(2):229-240.
28. Dong S.Z., Zhao S.P., Wu Z.H., et al. Curcumin promotes cholesterol efflux from adipocytes related to PPARgamma-LXRalpha-ABCA1 passway. Mol Cell Biochem 2011 Dec, 358(1-2):281-285.
29. Ishii T., Itoh K., Ruiz E., et al. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 2004 Mar 19, 94(5):609-616.